CORYNANTHE BARK EXTRACT AND ITS APPLICATION, MEDICINAL AGENT, FOOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT Russian patent published in 2010 - IPC A61K36/74 A61P13/00 A61P23/00 A61P5/00 A61P3/00 A61P9/00 

Abstract RU 2399378 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: corynanthe pachyceras bark extract is used for treatment and/or prevention of inferior urinary tract diseases, sexual disorders, disturbed lipid metabolism, cardiovascular diseases, and acute and chronic painful conditions, contains polyphenols and alkaloids. It is produced by the method involving: (a) extraction of dry and ground Corynanthe pachyceras with an organic solvent or a number of organic solvents mixed, or one or more organic solvents mixed with water at temperature 10°C to 100°C, with the organic solvent representing alcohol or ketone, (b) separation of the extracted plant and the extracting solution, e.g. by filtration, (c) if necessary, another extraction of the plant material by the solvent according to the stage (a) and separation according to the stage (b), (d) merge of the extracted solutions prepared at the stages (b) and (c), (e) evaporation and drying of the merged solution prepared at the stage (d), to produce a dry extract. The extract is used to make a medicinal agent, food and a pharmaceutical composition.

EFFECT: production of Corynanthe pachyceras bark extract used for treatment and/or prevention of inferior urinary tract diseases, sexual disorders, disturbed lipid metabolism, cardiovascular diseases, and acute and chronic painful conditions, and containing polyphenols and alkaloids.

9 cl, 2 ex

Similar patents RU2399378C2

Title Year Author Number
MEDICATION FOR TREATMENT AND PREVENTION OF PROSTATIC HYPERPLASIA, CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE 2006
  • Ju Dzae Jang
  • Choi Seul Min
  • Kang Kiung Koo
  • Akhn Bioung Ok
  • Joo Mookhi
RU2418590C2
FERMENTED MILK OR VEGETABLE PROTEINS, CONTAINING RECEPTOR LIGAND, AND THEIR APPLICATION 2005
  • Flambar Benedikt
RU2403051C2
PHARMACEUTICAL APPLICATION OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUND 2014
  • Lyu Khun
  • Se Sin
  • Sun Khajfen
  • Li Tszin
  • Chzhao Fej
  • Chen In
  • Li Tszen
  • Chzhou Yuj
  • Tszyan Khualyan
  • Chen Kajsyan
RU2704257C2
METHOD FOR THERAPEUTIC TREATMENT OF BENIGN HYPERPLASIA OF PROSTATE OR PROSTATE CANCER IN MAMMAL 1997
  • Ravert Jurgen
  • Rejssmann Tomas
  • Ritmjuller-Vintsen Khil'Da
  • Ehngel' Jurgen
RU2215537C2
COMPOSITIONS AND METHODS FOR IMPROVING THE STATE OF VASCULAR SYSTEM 2001
  • Shmits Garol'D G.
  • Shevo Kati A.
  • Dombroski Ehmi
  • Dzherom Ralf
RU2303373C2
USE OF COPAIFERA OLEORESINS IN PROSTATE PATHOLOGIES 2018
  • Ferini-Pyuibare, Kristel
RU2773173C2
COCOA EXTRACT COMPOUND AND METHODS OF ITS OBTAINING AND APPLICATION 2004
  • Romanzhik Leo Dzh. Ml.
  • Khammerstoun Dzhon F. Ml.
  • Buk Margaret M.
  • Post Lauri S.
  • Chipolla Dzhovanni G.
  • Makklelland Krejg A.
  • Mundt Dzheff A.
  • Shmitts Garol'D Kh.
RU2394562C2
APPLICATION OF SELECTIVE ANTAGONISTS OF ALPHA-1B-ADRENORECEPTORS FOR IMPROVEMENT OF STATE IN SEXUAL DYSFUNCTION 2000
  • Leonardi Amedeo
  • Motta Dzhanni
  • Testa Rodol'Fo
  • Sironi Dzhordzho
RU2239633C2
METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA 2013
  • Volkov Andrej Aleksandrovich
  • Petrichko Mikhail Ivanovich
  • Dukhin Anton Romanovich
RU2531944C1
METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA 2014
  • Bespalov Vladimir Grigor'Evich
  • Nekrasova Valerija Borisovna
RU2574014C2

RU 2 399 378 C2

Authors

Kokh Ehgon

Khauer Germann

Dates

2010-09-20Published

2006-11-07Filed